Deal Announcements

Exagen Adds Venture Equity And Debt Funding

Thursday, May 12, 2011 5:57:00 AM PDT | VentureDeal Staff

   Albuquerque, New Mexico  --  Biotechnology company Exagen Diagnostics has secured an additional $3.4 million in new venture capital equity and debt, according to an SEC regulatory filing.

Exagen is commercializing "small sets of genomic markers, providing prognostic regions for commercial laboratory testing and for pharmaceutical use in clinical trials."

Proceeds purposes were not disclosed. The amount may include options, warrants or other rights to acquire other securities.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1